EdgeRock Capital LLC Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

EdgeRock Capital LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.5% in the 2nd quarter, Holdings Channel.com reports. The fund owned 574 shares of the medical equipment provider’s stock after purchasing an additional 50 shares during the period. EdgeRock Capital LLC’s holdings in Intuitive Surgical were worth $311,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares during the period. Invesco Ltd. grew its position in Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after buying an additional 71,794 shares in the last quarter. Northern Trust Corp increased its stake in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after acquiring an additional 11,988 shares during the last quarter. Wellington Management Group LLP increased its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after acquiring an additional 457,080 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $1,715,899,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $438.12 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market cap of $157.06 billion, a price-to-earnings ratio of 61.10, a PEG ratio of 4.65 and a beta of 1.61. The firm has a 50 day moving average price of $470.98 and a 200-day moving average price of $501.82.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.78 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the sale, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent analyst reports. BTIG Research boosted their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. UBS Group boosted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Finally, Evercore ISI increased their target price on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research note on Tuesday, July 8th. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.